Small Molecules

15 Jun 2007 Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
14 Jun 2007 Chroma progresses novel cancer therapy CHR-2797 into Phase II solid tumour study; presents Pphase I data at ASCO
14 Jun 2007 Quest PharmaTech Completes the Enrollment of Patients in Phase I Clinical Study of SL017 Topical Gel for Photodynamic Therapy of Actinic Keratosis
14 Jun 2007 Ambrilia Presents Data on its Novel HIV Integrase Inhibitors at the XVI International HIV Drug Resistance Workshop
14 Jun 2007 FDA Advisory Committee Did Not Recommend Approval of Rimonabant (ZIMULTI(R)) for Use in Obese and Overweight Patients With Associated Risks Factors
14 Jun 2007 Depomed initiates dosing of patients in phase 2 trial for Gabapentin GR for the treatment of menopausal hot flashes
14 Jun 2007 Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo
14 Jun 2007 EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3 Clinical Trial at 47th Annual NCDEU Meeting
13 Jun 2007 ViroPharma Announces Completion of Enrollment in 500mg BID Arms of HCV-796 Phase 2 Study
13 Jun 2007 CuraGen Presents Update on Clinical Development Program for Belinostat
13 Jun 2007 Penwest Begins Dosing Phase IIa Clinical Study of Nalbuphine ER
13 Jun 2007 Kissei and Eisai sign a license agreement to develop and commercialize Glufast(R), a rapid-acting insulin secretagogue in 10 ASEAN countries
13 Jun 2007 Valopicitabine Combined with Standard of Care Cleared Hepatitis C Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a Phase II Trial
13 Jun 2007 Geron's telomerase inhibitor cancer drug demonstrates good pharmacokinetics and
13 Jun 2007 Par Pharmaceutical licenses commercialization rights to Pafuramidine for treatment of pneumocystis pneumonia
13 Jun 2007 BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
13 Jun 2007 FDA grants priority review for oral formulation of HYCAMTIN(R) (topotecan) to treat relapsed small cell lung cancer
13 Jun 2007 Neurocrine Announces Resubmission of New Drug Application for Indiplon Capsules
12 Jun 2007 Biotec Pharmacon enters Phase III with the diabetic ulcers indication
12 Jun 2007 Organon's sugammadex demonstrated a 9-12 times faster recovery in Phase III pivotal trial compared to neostigmine
12 Jun 2007 Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
12 Jun 2007 ACADIA Pharmaceuticals Initiates Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis
12 Jun 2007 GSK and Adolor Update Alvimopan (Entereg/Entrareg(R)) Development Program
12 Jun 2007 Clinical update – DEBIO 9902 (ZT-1) for Alzheimer’s disease
12 Jun 2007 Medivation's Dimebon(TM) Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimer's Disease Trial After One Year of Therapy

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up